{
    "nctId": "NCT00897455",
    "briefTitle": "Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers",
    "officialTitle": "Genetic Modifiers of BRCA1/BRCA2-Related Breast Cancer Risk in BRCA1/BRCA2 Mutation Carriers - CIMBA 5",
    "overallStatus": "UNKNOWN",
    "conditions": "brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 10000,
    "primaryOutcomeMeasure": "Identification of potential genetic modifiers of breast cancer risk",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Known positive BRCA1/BRCA2 mutation carrier\n* With or without a personal history of breast cancer prior to enrollment in clinical trial GOG-0199\n* Currently enrolled in clinical trial GOG-0199 AND meets the following criteria:\n\n  * Completed baseline questionnaire (BQ-199)\n  * Provided information on prior breast cancer history, including date of diagnosis\n  * Provided complete data from the DNA analysis on the genetic variants of interest\n  * Signed an approved informed consent and authorization permitting release of personal health information\n* Hormone receptor status not specified\n\nPATIENT CHARACTERISTICS:\n\n* Menopausal status not specified\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}